Boiron Coryzalia is a homeopathic medicine used for the relief of cold symptoms such as nasal congestion, runny nose, acute rhinitis, recurrent, infectious or allergic.
Directions:
Adults and children from 5 years old – Take 1 tablet every hour up to 12 tablets per day and reduce frequency with improvement. Chew the tablet and allow it to dissolve. Reduce with improvement.
Medicinal Ingredients:
- Allium cepa 3CH,
- Belladonna 3CH,
- Gelsemium sempervirens 3CH
- Kalium bichromicum 3CH,
- Pulsatilla 3CH
- Sabadilla 3CH.
Non-Medicinal Ingredients:
Sucrose, talc, acacia gum, magnesium stearate, carnauba wax, gelatin, white wax.
Warnings:
In case of fever or If symptoms persist or worsen for more than 48 hours, consult a health care practitioner.
Other Info:
Coryzalia does not require any special storage conditions.
We are only able to ship this item to Canadian customers.
Disclaimer: Under the Pharmacy Operations and Drug Scheduling Act, Iron Formula is a Schedule II drug, requiring a pharmacist’s intervention. No prescription is needed, but a pharmacist’s consultation is mandatory. After ordering online, our pharmacist will call you for a consultation, post which your product will be shipped.
Frequently Asked Questions About Boiron Coryzalia
Q: What is Boiron Coryzalia used for?
A: Coryzalia is a homeopathic medicine used for cold symptoms like runny nose, sneezing, nasal congestion, and minor sore throat.
Q: Is Boiron Coryzalia a homeopathic medicine?
A: Yes. Coryzalia is a homeopathic cold medicine made by Boiron.
Q: Does Coryzalia contain sugar or lactose?
A: Many Boiron homeopathic tablets contain sucrose or lactose. Check the label if you have diabetes or intolerance.
Q: Can children take Boiron Coryzalia tablets?
A: Check the exact label. Some Coryzalia tablet listings are for adults and children from 5 years old.
Q: When should I see a doctor for cold symptoms?
A: Seek care if symptoms worsen, last several days, include high fever, breathing trouble, ear pain, or severe sinus pain.
Reviews
There are no reviews yet.